Clinical Trial: Phase II Clinical Study on Preliminary Efficacy and Safety of ETD-001 Gel for Hypertrophic Scars

U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07891416) titled 'Phase II Clinical Study on Preliminary Efficacy and Safety of ETD-001 Gel for Hypertrophic Scars' on Oct. 08.

Brief Summary: A randomized, double-blind, placebo-controlled multiple dosing study to evaluate the preliminary efficacy and safety of ETD-001 gel for hypertrophic scars. Subjects will be assigned to 3 groups: ETD-001 Dose Group 1, ETD-001 Dose Group 2, and placebo group.

Study Start Date: Feb. 28, 2027

Study Type: INTERVENTIONAL

Condition: Hypertrophic Scars

Intervention: DRUG: ETD-001 gel

Topical investigational gel, multiple daily application on hypertrophic scar lesions for scheduled treatment period.

DRUG: ETD-0...